Latest Bausch & Lomb Incorporated. Stories

2014-09-26 08:25:40

Novel formulation, dosed twice daily, shows superiority to placebo (vehicle gel) in eliminating inflammation and pain following cataract surgery in Phase 3 study If approved, sub-micron loteprednol etabonate would be the first BID (or twice-day) ophthalmic steroid. Expect to file in the U.S. in Second Half of 2015 Expect to launch in the U.S. in Second Half of 2016 LAVAL, Quebec, Sept. 26, 2014 /PRNewswire/ -- Bausch + Lomb, a wholly owned subsidiary of Valeant Pharmaceuticals International,...

Word of the Day
  • A bat.
The word 'reremouse' comes from Middle English reremous, from Old English hrēremūs, hrērmūs ("bat"), equivalent to rear (“to move, shake, stir”) +‎ mouse.